A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
Clinical trial NCT05968599 · COMPLETED
Trial details
- NCT number
- NCT05968599
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-24
- Primary completion
- 2025-02-14
- Enrollment
- 2731
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.